Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 143,200
Avg Vol 1,132,574
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 58%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Nextel Medical Corp., a clinical stage biotechnology company, develops ways to exploit the therapeutic potential of exosomes for the field of oncology in the United States. The company was formerly known as Exousia Pro, Inc. and changed its name to Nextel Medical Corp. in April 2026. Nextel Medical Corp. was incorporated in 2010 and is based in Saint Petersburg, Florida.

Industry: Biotechnology
Sector: Healthcare
Phone: 509 605 6533
Address:
7901 4th Street N #23494, Saint Petersburg, United States
justFrog
justFrog Jun. 30 at 12:38 PM
$SNTX for $MAJI OS is 85 mil shares, sntx is 741 mil shares. Fair multiples in telehealth are 4-6x revenue. Just spreading the word as it's a low float play and anyone can make cash on that alone.
1 · Reply
yowatups04
yowatups04 Jun. 30 at 3:35 AM
$MAJI if this gets purchased by a larger company. Sky’s the limit on this stock.
0 · Reply
justFrog
justFrog Jun. 29 at 2:48 PM
$MAJI still room to hit 4-6 cents based on the $1.6 mil revenue alone. Hard to price in value for their cancer diagnostic test kit and exosome product lineup. The magic behind it all is they have a large existing customer network to sell any new products. I'm still aiming for 10 cents, but with float around 25 mil we can easily shoot past that. $NWBO $HYSR $SNTX $SGMO
3 · Reply
justFrog
justFrog Jun. 26 at 1:39 PM
$MAJI 4 to 6 cents immediate valuation based on being a telehealth with 1.6 mil sales. Still undervalued b ly at least. Sitting at 0.008 cents still! $SLS $QTEX $EVLI $WEN
2 · Reply
justFrog
justFrog Jun. 25 at 5:59 PM
$MAJI this guy gets it!
0 · Reply
justFrog
justFrog Jun. 25 at 5:58 PM
We gotta bring some life back to the $MAJI $1.6 mil revenue, $600K market cap, 20 mil float. Cancer diagnostic kit on the way. The exosomes might regrow your hair. What's not to like?? $SPYR $PHCG $VERU $ZENA
0 · Reply
justFrog
justFrog Jun. 25 at 5:19 PM
$SLS here but check out $MAJI too 1.6 mil revenue but valued at under 600k market cap. Has a cancer diagnostic test.
0 · Reply
yowatups04
yowatups04 Jun. 23 at 5:49 PM
$MAJI I mean added more to my balance. 🤠👍🏼
0 · Reply
yowatups04
yowatups04 Jun. 23 at 5:47 PM
$MAJI got me some of the MAJI! Let’s do this!
0 · Reply
silentsparrow
silentsparrow Jun. 23 at 12:33 PM
$MAJI sounds like they stopped dillution. Cash coming in pretty soon hopefully. I think they said 300k begining of july. Correct me if im wrong
0 · Reply
Latest News on MAJI
No data available.
justFrog
justFrog Jun. 30 at 12:38 PM
$SNTX for $MAJI OS is 85 mil shares, sntx is 741 mil shares. Fair multiples in telehealth are 4-6x revenue. Just spreading the word as it's a low float play and anyone can make cash on that alone.
1 · Reply
yowatups04
yowatups04 Jun. 30 at 3:35 AM
$MAJI if this gets purchased by a larger company. Sky’s the limit on this stock.
0 · Reply
justFrog
justFrog Jun. 29 at 2:48 PM
$MAJI still room to hit 4-6 cents based on the $1.6 mil revenue alone. Hard to price in value for their cancer diagnostic test kit and exosome product lineup. The magic behind it all is they have a large existing customer network to sell any new products. I'm still aiming for 10 cents, but with float around 25 mil we can easily shoot past that. $NWBO $HYSR $SNTX $SGMO
3 · Reply
justFrog
justFrog Jun. 26 at 1:39 PM
$MAJI 4 to 6 cents immediate valuation based on being a telehealth with 1.6 mil sales. Still undervalued b ly at least. Sitting at 0.008 cents still! $SLS $QTEX $EVLI $WEN
2 · Reply
justFrog
justFrog Jun. 25 at 5:59 PM
$MAJI this guy gets it!
0 · Reply
justFrog
justFrog Jun. 25 at 5:58 PM
We gotta bring some life back to the $MAJI $1.6 mil revenue, $600K market cap, 20 mil float. Cancer diagnostic kit on the way. The exosomes might regrow your hair. What's not to like?? $SPYR $PHCG $VERU $ZENA
0 · Reply
justFrog
justFrog Jun. 25 at 5:19 PM
$SLS here but check out $MAJI too 1.6 mil revenue but valued at under 600k market cap. Has a cancer diagnostic test.
0 · Reply
yowatups04
yowatups04 Jun. 23 at 5:49 PM
$MAJI I mean added more to my balance. 🤠👍🏼
0 · Reply
yowatups04
yowatups04 Jun. 23 at 5:47 PM
$MAJI got me some of the MAJI! Let’s do this!
0 · Reply
silentsparrow
silentsparrow Jun. 23 at 12:33 PM
$MAJI sounds like they stopped dillution. Cash coming in pretty soon hopefully. I think they said 300k begining of july. Correct me if im wrong
0 · Reply
Monkey115
Monkey115 Jun. 22 at 2:23 PM
$MAJI This should be multi pennies already !!!
1 · Reply
yowatups04
yowatups04 Jun. 18 at 8:53 PM
$MAJI love the low float and sounds like lots going on with the company as well.
0 · Reply
silentsparrow
silentsparrow Jun. 18 at 7:45 PM
$MAJI are we still scared of .08???
1 · Reply
justFrog
justFrog Jun. 18 at 4:51 PM
$MAJI this OTCN is an early investor selling. Once they're satisfied it should finally get back over a penny. Still very few eyes on this stock. Float should still be about 24 mil given the last update to it on OTC and adding in OS increases.
0 · Reply
yowatups04
yowatups04 Jun. 18 at 2:14 PM
$MAJI glad I jumped in this morning. Happy Thursday to this board! 🤠
0 · Reply
nakednoshorts
nakednoshorts Jun. 18 at 10:55 AM
$MAJI I’m looking at this one any catalyst? I usually dive in research first but time is limited any more
1 · Reply
BlazingStocks
BlazingStocks Jun. 17 at 7:28 PM
$MAJI - In addition to its current telehealth and diagnostic initiatives, NexTel is advancing a high-volume prescription-fulfillment program. Once fully operational, this program is projected to process approximately 2,000 prescriptions per day at an estimated $4.X per prescription https://finance.yahoo.com/healthcare/articles/nextel-medical-outlines-revenue-model-110000058.html
0 · Reply
BlazingStocks
BlazingStocks Jun. 17 at 6:35 PM
$MAJI - The company has integrated its recent acquisitions, JumpstartRx and NueVistraMed, to establish an immediate, non-dilutive, foundational revenue stream that is currently generating $135,000 to $140,000 per month. https://finance.yahoo.com/healthcare/articles/nextel-medical-outlines-revenue-model-110000058.html
0 · Reply
BlazingStocks
BlazingStocks Jun. 17 at 4:56 PM
$MAJI - This leadership trio bridges the critical gap that historically stalls biotech companies by connecting brilliant scientific discovery directly to an established, high-volume commercial pipeline. https://finance.yahoo.com/healthcare/articles/nextel-medical-outlines-revenue-model-110000058.html
0 · Reply
PrnceMichael
PrnceMichael Jun. 17 at 3:42 PM
$MAJI Now +7.79% @ .0083 Synergy of Advanced Medical Technologies and Massive Sales Infrastructure Primed to Drive Exponential Growth https://finance.yahoo.com/healthcare/articles/nextel-medical-outlines-revenue-model-110000058.html via @Yahoo
0 · Reply
UltimateTrader_22
UltimateTrader_22 Jun. 17 at 2:52 PM
$MAJI .0078 +1.30% @NexTelMedical on #NEWS NexTel Medical Outlines its Revenue Model Using the Innovation of Tomorrow as NexTel pairs saliva cancer test with network reaching 300,000 patients https://stocktitan.net/news/MAJI/nex-tel-medical-outlines-its-revenue-model-using-the-innovation-of-kmiufeuecis2.html
0 · Reply
BlazingStocks
BlazingStocks Jun. 17 at 2:43 PM
$MAJI - By seamlessly uniting its pioneering scientific innovations, recurring-revenue telehealth segments, and a massive, pre-existing patient distribution outlet, NexTel is positioning itself to rapidly commercialize next-generation medical solutions and maximize shareholder value. https://finance.yahoo.com/healthcare/articles/nextel-medical-outlines-revenue-model-110000058.html
0 · Reply